Through the new agreements, Cristal Therapeutics and McSAF will gain access to Lonza’s integrated bioconjugates offering and will be able to leverage Lonza’s expertise in developing and manufacturing bioconjugates
Through the collaboration, Lonza will gain access to Singzyme’s enzymatic conjugation platform enabling the site-specific binding of payloads with peptidic linkers to proteins of interest
They are GQ1005, an ADC with an excellent bystander killing effect, and GQ1007, a first-in-class antibody-immune-agonist-conjugate (AIAC) both with global intellectual property rights
Excluding Vacaville-related business, organic CER sales growth reached the low-teens with improved CORE EBITDA margins, in line with Lonza’s CDMO Organic Growth Model
LOTTE Biologics will provide advanced manufacturing services for monoclonal antibody intermediates and their conjugates
Grangemouth serves as PPS’s dedicated antibody-drug conjugate development and manufacturing hub
The antibody was designed and developed at Abzena’s Cambridge, UK,
New filling line approval supports delivery of integrated, end-to-end solutions across the entire biologics and bioconjugates value chain
This marks the first of four new U.S. manufacturing sites that Lilly plans to announce this year
Subscribe To Our Newsletter & Stay Updated
